BIOMAT Database Logo BIOMAT Database Logo

[Recommendations for the treatment of nosocomial infections caused by Gram-positive microorganisms]. 2004

J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
Sociedad Española de Quimioterapia (SEQ).

UI MeSH Term Description Entries
D002494 Central Nervous System Infections Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process. CNS Infections,Central Nervous System Infection,Infections, Central Nervous System,CNS Infection,Infection, CNS,Infections, CNS
D002985 Clinical Protocols Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy. Protocols, Clinical,Research Protocols, Clinical,Treatment Protocols,Clinical Protocol,Clinical Research Protocol,Clinical Research Protocols,Protocol, Clinical,Protocol, Clinical Research,Protocols, Clinical Research,Protocols, Treatment,Research Protocol, Clinical,Treatment Protocol
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial
D018410 Pneumonia, Bacterial Inflammation of the lung parenchyma that is caused by bacterial infections. Bacterial Pneumonia,Bacterial Pneumonias,Pneumonias, Bacterial
D018461 Soft Tissue Infections Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688) Infections, Soft Tissue,Infection, Soft Tissue,Soft Tissue Infection

Related Publications

J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
[Problems and current solutions for the treatment of infections caused by gram-positive microorganisms].
October 2001, Enfermedades infecciosas y microbiologia clinica,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
[Treatment of nosocomial pneumonias caused by gram positive cocci].
June 1994, Medicina clinica,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
[Alternative treatment in Gram-positive nosocomial infections ].
September 2004, Medecine et maladies infectieuses,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms.
January 2020, Microorganisms,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
Antibiotics for treatment of infections caused by gram-positive cocci.
May 1974, The Medical clinics of North America,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
Streptogramins for the treatment of infections caused by Gram-positive pathogens.
May 2021, Expert review of anti-infective therapy,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.
August 2007, Journal of chemotherapy (Florence, Italy),
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
[Ocular infections caused by gram negative microorganisms].
January 1971, Bulletin de la Societe belge d'ophtalmologie,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
The fluoroquinolones as treatment for infections caused by gram-positive bacteria.
March 1994, The Journal of antimicrobial chemotherapy,
J R Azanza, and J Barberán, and J A García-Rodríguez, and P Llinares, and J Mensa, and J Picazo, and J Prieto, and J Torre Cisneros
[Efficacy and tolerance of teicoplanin in postoperative infections caused by gram-positive microorganisms].
September 1987, Minerva chirurgica,
Copied contents to your clipboard!